MARKET

AWH

AWH

Aspira Womens Health Inc
NASDAQ
0.3899
+0.0098
+2.58%
Opening 12:59 10/04 EDT
OPEN
0.3790
PREV CLOSE
0.3801
HIGH
0.3938
LOW
0.3661
VOLUME
157.49K
TURNOVER
47.31K
52 WEEK HIGH
3.510
52 WEEK LOW
0.3210
MARKET CAP
43.78M
P/E (TTM)
-1.2086
1D
5D
1M
3M
1Y
5Y
At U.N., emotional appeals for world leaders to protect Afghan girls' education
At U.N., emotional appeals for world leaders to protect Afghan girls' education
Reuters · 09/21 05:00
Aspira Women's Health Announces Publication Of Second-Generation MultiVariate Index Assay, OVERA, In Detection Of Cancer In Filipino Women
Aspira Women's Health Inc. ("Aspira"), a bio-analytical based women's health company focused on gynecologic disease, today announced publication of a study on the use of its multivariate index assay,
Benzinga · 09/12 20:30
UPDATE 1-U.S. retailers slash clothing prices as shoppers cut purchases
UPDATE 1-U.S. retailers slash clothing prices as shoppers cut purchases
Reuters · 08/25 20:54
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers
Benzinga · 08/24 09:56
Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday.
Benzinga · 08/23 19:07
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Benzinga · 08/23 17:52
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday.
Benzinga · 08/23 16:31
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 08/23 16:14
More
About AWH
Aspira Women’s Health Inc. is engaged in discovering, developing and utilization of testing options and bio-analytical solutions. Its products include OVA1 and Overa, OVA1plus, Aspira GenetiX and Aspira Synergy. OVA1 is a blood test that is intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical, and Overa is intended to maintain OVA1’s high sensitivity. OVA1plus is a reflex test performed for those OVA1 test results that are in the intermediate risk range. Aspira GenetiX is a genetic test for gynecologic cancer risk, with a focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers. Aspira Synergy is an en-suite, cloud-based technology transfer solution that provides an end-to-end solution from specimen collection to a customized white-label report for clinical laboratories to internalize testing of its products.

Webull offers kinds of Aspira Women's Health Inc stock information, including NASDAQ:AWH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AWH stock methods without spending real money on the virtual paper trading platform.